Survival Disparities of Diffuse Large B-Cell Lymphoma (DLBCL) in a Community-Based Inner-City Cancer Center
There is persistent racial disparities in survival among patients with Diffuse Large B Cell Lymphoma. We conducted a cohort study of 181 patients for 10 years in a single community-based inner-city cancer center. Blacks had decreased overall survival compared to non-Blacks even after excluding patients with HIV and who did not receive chemotherapy. R-IPI score alone could not predict worse outcomes and increased mortality in Blacks with DLBCL.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Andrew Tiu, Vinicius Jorge, Peter Moussa, Djeneba Audrey Djibo, Sorab Gupta, Onder Alpdogan, Claudia Dourado Tags: Original Study Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Hematology | Leukemia | Lymphoma | Myeloma | Study